AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17230043 — intervention group
Group type: COMPARATOR
Intervention: KYSt‐10 strawberry variety
Number of subjects: 2
Study 17230043 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 2
Study 14604303 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 vaginal pessary (5% concentration) used at bedtime for 14 days
Number of subjects: 23
Study 14604303 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 vaginal pessary
Number of subjects: 23
Study 10924008 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 200 mg/day
Number of subjects: 100
Study 10924008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 8984354 — intervention group
Group type: EXPERIMENTAL
Intervention: Gang board
Number of subjects: 220
Study 8984354 — intervention group
Group type: EXPERIMENTAL
Intervention: Romberg's test
Number of subjects: 220
Study 8984354 — intervention group
Group type: EXPERIMENTAL
Intervention: Tandem gait
Number of subjects: 220
Study 8984354 — intervention group
Group type: EXPERIMENTAL
Intervention: One‐leg‐stance
Number of subjects: 220
Study 8984354 — intervention group
Group type: EXPERIMENTAL
Intervention: Hopping
Number of subjects: 220
Study 8984354 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall balance tests
Number of subjects: 220
Study 1574966 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEPO) therapy, 150 U/kg given subcutaneously 3 times weekly
Number of subjects: 0
Study 3930686 — intervention group
Group type: EXPERIMENTAL
Intervention: Premature formula (PF)
Number of subjects: 0
Study 3930686 — intervention group
Group type: EXPERIMENTAL
Intervention: Own mother's milk (OMM)
Number of subjects: 0
Study 3930686 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (SF)
Number of subjects: 0
Study 3930686 — intervention group
Group type: COMPARATOR
Intervention: Casein-predominant cow's milk formula (CF)
Number of subjects: 0
Study 30479020 — intervention group
Group type: EXPERIMENTAL
Intervention: BRief Evaluation of Asthma THerapy intervention (7‐min shared decision‐making protocol)
Number of subjects: 80
Study 30479020 — intervention group
Group type: COMPARATOR
Intervention: Dose-matched attention control
Number of subjects: 80
Study 30257654 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-led multifactorial back education programme
Number of subjects: 176
Study 30257654 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 176
Study 30257654 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 176
Study 26465641 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine
Number of subjects: 105
Study 26465641 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine and fentanyl
Number of subjects: 105
Study 26465641 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric bupivacaine, fentanyl and MgSO4
Number of subjects: 105
Study 24449415 — intervention group
Group type: COMPARATOR
Intervention: Sonographic (US) images with arrows pointing to specific anatomic structures (Group A)
Number of subjects: 54
Study 24449415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonographic (US) images with arrows plus MRI/US fusion images (Group B)
Number of subjects: 54
Study 24449415 — intervention group
Group type: COMPARATOR
Intervention: Sonographic (US) images with arrows (Group A)
Number of subjects: 54
Study 21912268 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance exercise program
Number of subjects: 24
Study 21912268 — intervention group
Group type: COMPARATOR
Intervention: Attention control wait list (ACWL)
Number of subjects: 24
Study 19834462 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Self-Stigma Questionnaire (WSSQ)
Number of subjects: 169
Study 18555931 — intervention group
Group type: EXPERIMENTAL
Intervention: Branded risedronate sodium 35-mg tablet
Number of subjects: 20
Study 18555931 — intervention group
Group type: COMPARATOR
Intervention: Generic alendronic acid 70-mg tablet (Novopharm Limited)
Number of subjects: 20
Study 18555931 — intervention group
Group type: COMPARATOR
Intervention: Generic alendronic acid 70-mg tablet (Teva UK Limited)
Number of subjects: 20
Study 18555931 — intervention group
Group type: COMPARATOR
Intervention: Semisupine position
Number of subjects: 20
Study 18555931 — intervention group
Group type: COMPARATOR
Intervention: Novopharm tablet
Number of subjects: 20
Study 15768430 — intervention group
Group type: EXPERIMENTAL
Intervention: 915 MHz microwaves (SAR 37 mW/kg)
Number of subjects: 0
Study 15768430 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Hz magnetic field (15 muT peak value)
Number of subjects: 0
Study 15768430 — intervention group
Group type: COMPARATOR
Intervention: Heat shock at 41 degrees C
Number of subjects: 0
Study 12425364 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinastine 20 mg
Number of subjects: 0
Study 12425364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 0
Study 12425364 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10874374 — intervention group
Group type: EXPERIMENTAL
Intervention: Education on asthma
Number of subjects: 36
Study 10874374 — intervention group
Group type: COMPARATOR
Intervention: Education on urinary tract infections
Number of subjects: 36
Study 10874374 — intervention group
Group type: EXPERIMENTAL
Intervention: Group discussions
Number of subjects: 36
Study 10874374 — intervention group
Group type: EXPERIMENTAL
Intervention: CME activities
Number of subjects: 36
Study 10874374 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in CME
Number of subjects: 36
Study 8621275 — intervention group
Group type: EXPERIMENTAL
Intervention: RRP plus RT
Number of subjects: 288
Study 8621275 — intervention group
Group type: COMPARATOR
Intervention: RRP without RT
Number of subjects: 288
Study 8621275 — intervention group
Group type: EXPERIMENTAL
Intervention: RRP plus neoadjuvant hormonal therapy
Number of subjects: 288
Study 8621275 — intervention group
Group type: COMPARATOR
Intervention: RRP without hormonal therapy
Number of subjects: 288
Study 8621275 — intervention group
Group type: EXPERIMENTAL
Intervention: RRP plus RT (no SV invasion)
Number of subjects: 288
Study 8621275 — intervention group
Group type: COMPARATOR
Intervention: RRP without RT (no SV invasion)
Number of subjects: 288
Study 8621275 — intervention group
Group type: EXPERIMENTAL
Intervention: RRP plus RT (SV invasion)
Number of subjects: 288
Study 8621275 — intervention group
Group type: COMPARATOR
Intervention: RRP without RT (SV invasion)
Number of subjects: 288
Study 8621275 — intervention group
Group type: COMPARATOR
Intervention: RRP alone
Number of subjects: 288
Study 8621275 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant therapies
Number of subjects: 288
Study 1874764 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation and volitional exercise
Number of subjects: 10
Study 1874764 — intervention group
Group type: COMPARATOR
Intervention: Volitional exercise alone
Number of subjects: 10
Study 1874764 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Number of subjects: 10
Study 7154888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp slope of 20 W X min‐1
Number of subjects: 14
Study 7154888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp slope of 30 W X min‐1
Number of subjects: 14
Study 7154888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp slope of 50 W X min‐1
Number of subjects: 14
Study 7154888 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp slope of 100 W X min‐1
Number of subjects: 14
Study 30548555 — intervention group
Group type: EXPERIMENTAL
Intervention: ProDesign R [PDR; size 25, .06 taper; Easy, Belo Horizonte, Brazil]
Number of subjects: 30
Study 30548555 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtwo [MO; size 25, .06 taper; VDW, Munich, Germany]
Number of subjects: 30
Study 30548555 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc [REC; size 25, .08 taper; VDW, Munich, Germany]
Number of subjects: 30
Study 30548555 — intervention group
Group type: EXPERIMENTAL
Intervention: All NiTi systems
Number of subjects: 30
Study 30278067 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous TXA (10 mg/kg)
Number of subjects: 170
Study 30278067 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical TXA (3 g)
Number of subjects: 170
Study 30278067 — intervention group
Group type: COMPARATOR
Intervention: Topical placebo (60 ml physiological saline)
Number of subjects: 170
Study 27794079 — intervention group
Group type: EXPERIMENTAL
Intervention: VT‐NIV
Number of subjects: 58
Study 27794079 — intervention group
Group type: COMPARATOR
Intervention: PL‐NIV
Number of subjects: 58
Study 25278226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous insulin therapy during lung resection
Number of subjects: 64
Study 25278226 — intervention group
Group type: COMPARATOR
Intervention: Control group (no insulin treatment)
Number of subjects: 64
Study 23180045 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 0
Study 23180045 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study 20138941 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention groups focused on dietary changes including reduction of daily fat intake and increased intake of fruit, vegetables, and fiber.
Number of subjects: 62565
Study 20138941 — intervention group
Group type: COMPARATOR
Intervention: Control group (active control)
Number of subjects: 62565
Study 20138941 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyp Prevention Trial (specific intervention)
Number of subjects: 62565
Study 17358096 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectally administered oxcarbazepine suspension (300 mg and 450 mg doses)
Number of subjects: 10
Study 17358096 — intervention group
Group type: COMPARATOR
Intervention: Oral administration of oxcarbazepine
Number of subjects: 10
Study 15646602 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride varnish applied three times within a single week
Number of subjects: 10
Study 15646602 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish applied in a single application
Number of subjects: 10
Study 11591619 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term HTRs
Number of subjects: 21
Study 11591619 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term HTRs
Number of subjects: 21
Study 11591619 — intervention group
Group type: COMPARATOR
Intervention: Hypertensive patients
Number of subjects: 21
Study 9520888 — intervention group
Group type: EXPERIMENTAL
Intervention: Suction drainage
Number of subjects: 69
Study 9520888 — intervention group
Group type: COMPARATOR
Intervention: No suction drainage
Number of subjects: 69
Study 7988364 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT; <= 25 mg daily)
Number of subjects: 69
Study 7988364 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HCT)
Number of subjects: 69
Study 3141491 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day parenteral folinic acid
Number of subjects: 105
Study 3141491 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/week parenteral folinic acid
Number of subjects: 105
Study 3141491 — intervention group
Group type: COMPARATOR
Intervention: No parenteral folinic acid (Control Group)
Number of subjects: 105
Study 3141491 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral and enteral administration of folate (300 micrograms/day folic acid)
Number of subjects: 105
Study 31280481 — intervention group
Group type: EXPERIMENTAL
Intervention: Anidulafungin 200 mg IV loading dose followed by 100 mg daily maintenance dose
Number of subjects: 79
Study 31280481 — intervention group
Group type: EXPERIMENTAL
Intervention: Anidulafungin treatment
Number of subjects: 79
Study 27639927 — intervention group
Group type: EXPERIMENTAL
Intervention: Full nine-item Reproductive Coercion Scale (RCS)
Number of subjects: 4674
Study 27639927 — intervention group
Group type: EXPERIMENTAL
Intervention: Short five-item Reproductive Coercion Scale (RCS)
Number of subjects: 4674
Study 26372451 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib‐MenC‐TT vaccine
Number of subjects: 433
Study 26372451 — intervention group
Group type: COMPARATOR
Intervention: Hib + MCC vaccines
Number of subjects: 433
Study 23444884 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational board game
Number of subjects: 67
Study 23444884 — intervention group
Group type: COMPARATOR
Intervention: Control group (no game)
Number of subjects: 67
Study 22132800 — intervention group
Group type: EXPERIMENTAL
Intervention: Low GI meal without fructose (LGI)
Number of subjects: 10
Study 22132800 — intervention group
Group type: EXPERIMENTAL
Intervention: Low GI meal with fructose beverage (LGIF)
Number of subjects: 10
Study 22132800 — intervention group
Group type: EXPERIMENTAL
Intervention: High GI meal (HGI)
Number of subjects: 10
Study 22132800 — intervention group
Group type: EXPERIMENTAL
Intervention: All trials (LGI, LGIF, HGI)
Number of subjects: 10
Study 19364291 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg of MPH
Number of subjects: 58
Study 19364291 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg of MPH
Number of subjects: 58
Study 19364291 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg of MPH
Number of subjects: 58
Study 19364291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 19364291 — intervention group
Group type: EXPERIMENTAL
Intervention: DAT SLC6A3 genotype
Number of subjects: 58
Study 19364291 — intervention group
Group type: EXPERIMENTAL
Intervention: DRD2 genotype
Number of subjects: 58
Study 16133044 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (0.2 mg/kg, infused continuously over 15 min)
Number of subjects: 44
Study 16133044 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (initial dose of 10 mg/kg followed by two doses of 5 mg/kg each after 24 and 48 h)
Number of subjects: 44
Study 10628766 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone withdrawal (tapered over 8 weeks to 0 mg/day)
Number of subjects: 266
Study 10628766 — intervention group
Group type: COMPARATOR
Intervention: Prednisone maintenance (10 mg/day)
Number of subjects: 266
Study 10628766 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone withdrawal
Number of subjects: 266
Study 7707112 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose experimental therapy
Number of subjects: 115
Study 7707112 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment or experimental agent
Number of subjects: 115
Study 7707112 — intervention group
Group type: EXPERIMENTAL
Intervention: Different therapies for a 6-month addition to life expectancy
Number of subjects: 115
Study 7707112 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for a 5-year increase in length of survival
Number of subjects: 115
Study 7707112 — intervention group
Group type: COMPARATOR
Intervention: Randomization to a clinical trial comparing high-dose with standard chemotherapy
Number of subjects: 115
Study 2390879 — intervention group
Group type: EXPERIMENTAL
Intervention: Inosine, 50‐90 mg/kg daily in divided doses
Number of subjects: 36
Study 7023207 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose trimethoprim (200 mg)
Number of subjects: 96
Study 7023207 — intervention group
Group type: COMPARATOR
Intervention: Five-day course of trimethoprim (200 mg b.d.)
Number of subjects: 96
Study 31103123 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong practice (Guan Yin Zi Zai Gong level 1) for one hour per week for six weeks, encouraged to practice daily at home.
Number of subjects: 72
Study 31103123 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group received general advice regarding low back pain management.
Number of subjects: 72
Study 31103123 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong practice (Guan Yin Zi Zai Gong level 1)
Number of subjects: 72
Study 30658378 — intervention group
Group type: EXPERIMENTAL
Intervention: Coca-Cola
Number of subjects: 150
Study 30658378 — intervention group
Group type: EXPERIMENTAL
Intervention: Fanta Orange Soda
Number of subjects: 150
Study 30658378 — intervention group
Group type: EXPERIMENTAL
Intervention: Guaraná Antarctica
Number of subjects: 150
Study 30658378 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprite
Number of subjects: 150
Study 30658378 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (Control)
Number of subjects: 150
Study 26805435 — intervention group
Group type: EXPERIMENTAL
Intervention: Rufinamide
Number of subjects: 37
Study 26805435 — intervention group
Group type: COMPARATOR
Intervention: Any other approved AED
Number of subjects: 37
Study 24004292 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (200,000 IU for 2 months, then 100,000 IU monthly for 18 months)
Number of subjects: 322
Study 24004292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322
Study 22453821 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based reflection with trained facilitators meeting for up to eleven 1-hour meetings.
Number of subjects: 4
Study 19089875 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention program delivered by caregivers
Number of subjects: 27
Study 19089875 — intervention group
Group type: COMPARATOR
Intervention: Home safety assessment control
Number of subjects: 27
Study 17671064 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine
Number of subjects: 128
Study 17671064 — intervention group
Group type: COMPARATOR
Intervention: Dopamine
Number of subjects: 128
Study 17671064 — intervention group
Group type: COMPARATOR
Intervention: Combined rates of death or disability
Number of subjects: 128
Study 17671064 — intervention group
Group type: EXPERIMENTAL
Intervention: Low superior vena cava flow
Number of subjects: 128
Study 17671064 — intervention group
Group type: EXPERIMENTAL
Intervention: Low superior vena cava flow and lower gestational age
Number of subjects: 128
Study 17671064 — intervention group
Group type: EXPERIMENTAL
Intervention: Low superior vena cava flow and birth weight <10th percentile
Number of subjects: 128
Study 17671064 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants treated with inotropes
Number of subjects: 128
Study 15826232 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-switch preparation
Number of subjects: 0
Study 15826232 — intervention group
Group type: EXPERIMENTAL
Intervention: Time deadlines for optimal advance preparation
Number of subjects: 0
Study 12138146 — intervention group
Group type: EXPERIMENTAL
Intervention: gentamicin/citrate (40 mg/ml and 3.13% citrate; ratio 2:1)
Number of subjects: 83
Study 12138146 — intervention group
Group type: COMPARATOR
Intervention: heparin (5000 U/ml)
Number of subjects: 83
Study 9570264 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic solution (160 mOsmol/kg)
Number of subjects: 8
Study 9570264 — intervention group
Group type: COMPARATOR
Intervention: Isotonic solution
Number of subjects: 8
Study 9570264 — intervention group
Group type: EXPERIMENTAL
Intervention: Both hypotonic and isotonic solutions
Number of subjects: 8
Study 7641409 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg oral temazepam
Number of subjects: 21
Study 7641409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 2568767 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium (0.1, 0.2, 0.4, or 1 mg/kg)
Number of subjects: 90
Study 2568767 — intervention group
Group type: EXPERIMENTAL
Intervention: Neostigmine (0.005, 0.01, 0.02, or 0.05 mg/kg)
Number of subjects: 90
Study 2568767 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium (0.44 +/- 0.11 mg/kg with atracurium and 0.46 +/- 0.12 mg/kg with vecuronium)
Number of subjects: 90
Study 2568767 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 subjects allowed to recover spontaneously)
Number of subjects: 90
Study 31084558 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation at 19.11 J/cm2
Number of subjects: 5
Study 31084558 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation at 25.47 J/cm2
Number of subjects: 5
Study 31084558 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation at 6.37 J/cm2
Number of subjects: 5
Study 31084558 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation at 12.73 J/cm2
Number of subjects: 5
Study 31084558 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation (various energy densities)
Number of subjects: 5
Study 27892890 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (10mg OD) plus acetylsalicylic acid (ASA, 75-100mg OD) for 90 days followed by rivaroxaban alone
Number of subjects: 1520
Study 27892890 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel (75mg OD) plus ASA for 90 days followed by ASA alone
Number of subjects: 1520
Study 25558975 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor control therapy
Number of subjects: 0
Study 25558975 — intervention group
Group type: EXPERIMENTAL
Intervention: General active exercise therapy
Number of subjects: 0
Study 25558975 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training therapy
Number of subjects: 0
Study 24064198 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-delivered cognitive behavior therapy (iCBT)
Number of subjects: 22
Study 24064198 — intervention group
Group type: COMPARATOR
Intervention: ABM (Attention Bias Modification)
Number of subjects: 22
Study 24064198 — intervention group
Group type: EXPERIMENTAL
Intervention: iCBT
Number of subjects: 22
Study 21235821 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week program of intensive unilateral hand training using an instrumented exercise workstation and functional electrical stimulation
Number of subjects: 78
Study 21235821 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 78
Study 19779321 — intervention group
Group type: EXPERIMENTAL
Intervention: Lersivirine (UK-453,061) 10 mg twice daily
Number of subjects: 48
Study 19779321 — intervention group
Group type: EXPERIMENTAL
Intervention: Lersivirine (UK-453,061) 30 mg twice daily
Number of subjects: 48
Study 19779321 — intervention group
Group type: EXPERIMENTAL
Intervention: Lersivirine (UK-453,061) 100 mg twice daily
Number of subjects: 48
Study 19779321 — intervention group
Group type: EXPERIMENTAL
Intervention: Lersivirine (UK-453,061) 500 mg twice daily
Number of subjects: 48
Study 19779321 — intervention group
Group type: EXPERIMENTAL
Intervention: Lersivirine (UK-453,061) 100 mg once daily
Number of subjects: 48